Upon hypoxia the human erythropoietin (EPO) gene is transactivated by the heterodimeric hypoxia-inducible factor 1 (HIF-1). Mammalian SWI/SNF is a chromatin-remodeling complex involved in modulation of gene expression. We demonstrate that Brahma (Brm) and Brahma/SWI2-Related Gene 1 (Brg-1), alternative ATPase subunits of SWI/SNF, potentiate 
INTRODUCTION
Tissue oxygen concentration is an important regulatory stimulus for many physiological and pathological processes (1) . Adaptation to hypoxia depends in part on appropriate alterations in the expression of a number of physiologically relevant genes. Induction of the erythropoietin (EPO) 5 gene by hypoxia is central to the regulation of the oxygen-carrying capacity of the blood (2) . Hypoxic induction of genes encoding angiogenic growth factors such as vascular endothelial growth factor (VEGF) leads to new blood vessel formation during development, wound repair, and tumor growth (3) (4) (5) . Most if not all mammalian cell types share a common mechanism of oxygen sensing and signal transduction (6) , enabling hypoxia-induced activation of the transcription factor hypoxia-inducible factor 1 (HIF-1) composed of HIF-1α and Arnt (7) . The HIF-1α subunit is regulated by hypoxia both at the level of transactivation and protein stability (8) (9) (10) (11) .
In general, gene expression is not determined by the simple additive influences of individual transcription factor binding sites. Adjacent sites interact with each other to produce effects which range from repressive to highly synergistic. Multiprotein complexes involving transcription factors, coactivator proteins, and other proteins are thought to integrate signals and create the specificity and control required for precise regulation of gene transcription.
Despite similarities among hypoxia-responsive genes, there are important differences. While EPO expression can be induced as much as 100-fold, other responses to hypoxia are less robust.
Hypoxic inducibility can be modulated by other environmental stimuli as well as tissue-specific cues (12) . Transcriptional regulation of the EPO gene is achieved by the concerted action of several transacting factors interacting with the proximal promoter region and with the 3' untranslated region of the gene (13) (14) (15) (16) (17) . In the 3' untranslated region there is a hypoxiaresponsive-enhancer element located approximately 120 bp 3' from the polyadenylation site.
This enhancer element is functionally tripartite. One site binds HIF-1 (17) . The second site is necessary for transactivation of the EPO gene mediated by HIF-1, but factors interacting with this site have not yet been described. The third is a binding site for the orphan receptor, hepatocyte nuclear factor 4 (HNF4) (18) . In addition, a binding site for Smad4 was recently identified that partially overlaps the HNF4 binding site (19) . The coactivator protein p300 has been shown to interact with HIF-1 , and to be required for enhanced transcription of the EPO and VEGF genes in response to hypoxia (20) . Both the HIF-1 site and the adjacent, functionally critical nuclear HNF4 site, are required for high-affinity binding of p300 and formation of a hypoxically inducible multiprotein complex (21) . 
EXPERIMENTAL PROCEDURES
Plasmid Constructs and Vectors--pBJ5-BRG-1 and pBJ5-BRG-1 (K785R) were kind gifts of Dr. Myles Brown. pCG-Brm and pCG-Brm (K749R) were described previously (28) . Reporters 6 X HRE-SV40-luc and EPO enhancer-SV40-luc were kind gifts from Dr. Greg Semenza and Dr. Franklin Bunn respectively. The pBos-hHIF-1α plasmid was described previously (29) .
Cell Culture and antibodies--The SW-13 adrenal carcinoma and Hep3B cell lines were grown in Dulbecco's modified Eagle medium (Invitrogen) with 10% fetal calf serum (Omega), Lglutamine (Invitrogen), fungizone, and penicillin-streptomycin (Invitrogen) at 37 °C and 5% CO 2 . The Brm (N-19), Brg-1 (H-88) and HIF-1α (Η−206) antibodies used for the ChIP assays were purchased from Santa Cruz Biotechnology. The Brm antibody used for Western blotting was purchased from BD Transduction Laboratories. Antibody to Ac-K5, K8-H4 was purchased from Upstate Biotechnology. The affinity-purified rabbit polyclonal antibody to ARNT was described previously (30) .
Transient Transfections and Reporter
Gene Assay-Expression plasmids were transfected into SW-13 cells cultured in 12 well-plates by using the GenePorter 2 (Gene Therapy System) transfection reagent. After 24 h, some of the plates were exposed to hypoxia (1% O 2 , 94% N 2 and 5% CO 2 ) for 24 h. Cells were then harvested and lysed in Passive lysis buffer (Promega).
Luciferase activities were measured using the Dual-luciferase system (Promega) with the protocol recommended by the manufacturer. All transfection experiments were performed in triplicate.
RNA interference in Hep3B cells-SiRNA for Brm (siBrm) was prepared using the Dicer siRNA Generation Kit (Gene Therapy System) according to the protocol recommended by the manufacturer. Briefly, Brm cDNA between +141 and +733 relative to the translation start site was amplified by PCR using a forward primer (5'-CCTGGACCTCCAAGTGTCTC-3') and a reverse primer (5'-GGCCAGATGGTCTGTTGTAG-3'). The amplicon was used as the template for in vitro transcription by T7 RNA polymerase. The double-strand RNA so produced was 
RESULTS

Transcriptional induction of the EPO gene is associated with modifications of histones at the
EPO promoter-Histone-modifying complexes are thought to cooperate with histone-remodeling complexes to reconfigure chromatin, thereby establishing a local chromatin structure that is permissive for the subsequent assembly of an active preinitiation complex (PIC) at the promoter and Brm-deficient human adrenal carcinoma cell line SW-13, with EPO enhancer-SV40-luc ( Fig. 2A) , a reporter in which the luciferase gene is driven by an EPO 3' enhancer fragment containing all the cis-DNA elements described above and a minimal SV40 promoter. We found that both Brm and Brg-1, alternative ATPase subunits of SWI/SNF, enhanced the reporter luciferase activity in a hypoxia-dependent manner (Fig. 2B ). Since the activity of this reporter is relatively weak and the expression of HIF-1α appeared to be relatively low in SW-13 cells, we also co-transfected a HIF-1α expressing plasmid together with Brg-1 and/or Brm along with the reporter in most transfections in order to obtain maximal expression of the reporter gene.
Whereas transfection of HIF-1α alone only marginally increased the reporter activity, this activity was further increased markedly by cotransfection with either Brg-1 or Brm. The expression of the reporter was in some instances also enhanced to some extent by Brm and Brg-1 even under normoxic conditions, most probably due to the over expression of HIF-1α leading to its activity even under these conditions. Interestingly, when Brm and Brg-1 were co-transfected,
we did not observe a further enhancement of the reporter activity, indicating that the two factors do not enhance EPO transcription in an additive or synergistic manner. We found that Brm was more potent than Brg-1 with regard to enhancing reporter gene transcription ( together. First, we studied the role of Brm using a pool of small interference RNA oligos (siBrm). Endogenous Brm was knocked down at both the mRNA and protein level in the human hepatoma Hep3B cell line transfected with siBrm, while the level of Brg-1 mRNA was not affected (Fig. 4A) . Depletion of Brm resulted in a moderate reduction in transcription of the endogenous EPO gene triggered by hypoxia (Fig. 4B) . The expression of endogenous Brg-1 was knocked down by a single small interfering RNA oligo nucleotide (siBrg-1) at both the mRNA and protein level in Hep3B cells. Interestingly, the level of Brm mRNA was increased by this treatment (Fig. 4C ). Also surprisingly, the level of EPO mRNA in the presence of hypoxia was enhanced by depletion of endogenous Brg-1 (Fig. 4D ). Since Brm is more effective than Brg-1 in enhancing the HIF-1-mediated transcription of the reporter genes, the enhancement might result from the increased amount of Brm compensating for the lack of Brg-1. Brm may take the place of Brg-1 in SWI/SNF complexes, and such complexes may potentiate transcription of the EPO gene more efficiently than SWI/SNF containing Brg-1. Finally, we depleted Brm and Brg-1 simultaneously using a small interference RNA oligo nucleotide which recognizes both Brm and Brg-1 mRNAs (siB/B). As shown in Fig. 4E , both Brm and Brg-1 were knocked down at the mRNA and protein level, and this resulted in a significant reduction in transcription of the EPO gene induced by hypoxia (Fig. 4F) . To investigate whether SWI/SNF potentiates transcription of HIF-1-regulated genes in general, we examined the transcription of VEGF. Interestingly, though the transcription of VEGF is induced by hypoxia via HIF-1, none of the three siRNAs affected the levels of its mRNA induced by hypoxia (Fig. 4B, D 
Brm and Brg-1 Are Recruited to the 3' Enhancer Region of the EPO gene in Response to
Hypoxic Stimulation-Studies in yeast demonstrate that SWI/SNF complexes can localize to specific gene promoters, disrupting nucleosomal DNA to modulate transcription (35) (36) (37) ). The precise mechanism through which SWI/SNF regulates gene promoters in mammals is unresolved, however it was reported recently that in mammalian cells, SWI/SNF complexes can be recruited by transcription factors to specific gene promoters in vivo (38, 39) . In conclusion, our observations indicate that the EPO gene is a novel target gene of the SWI/SNF chromatin-remodeling complex, but that the requirement for this complex is gene specific. To our knowledge, this is the first reported investigation on the roles of ATPase chromatinremodeling factors in transcriptional activation by HIF-1, and it reveals a novel mechanism through which Brm and its homologue Brg-1 might compensate for each other functionally to fulfill chromatin remodeling. 
